Stocktoria
Nexentis Technologies Inc. NXTS
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2010-05-26
Nexentis Technologies Inc. financials (annual)
Bars are annual figures from 2018 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $210,000 | $263,445 | $394,004 | $438,141 | $232,274 | $175,823 | $426,591 |
| Gross profit | — | $45,000 | $208,000 | $235,691 | $302,198 | $188,869 | $31,275 | $315,500 |
| R&D expense | $179,000 | $369,000 | $1.9M | $770,826 | $538,684 | $417,000 | $615,623 | $357,077 |
| Operating income | -$4.2M | -$3.3M | -$7.6M | -$5.8M | -$4.7M | -$1.3M | -$1.9M | -$518,659 |
| Interest expense | — | $16 | — | — | — | — | — | — |
| Income tax | -$18,000 | — | — | — | — | — | — | — |
| Net income | -$4.0M | -$5.2M | -$6.5M | -$5.7M | -$4.8M | -$1.6M | -$2.0M | -$356,893 |
| EPS (diluted) | $-8.61 | $-27.74 | $-5.43 | $10.85 | — | — | — | — |
| Operating cash flow | -$3.8M | -$3.4M | -$3.2M | -$5.1M | -$4.1M | -$798,740 | -$1.2M | -$506,499 |
| Free cash flow | -$3.8M | — | — | -$5.1M | -$4.2M | — | -$1.3M | -$509,028 |
| Cash & equivalents | $3.8M | $1.9M | $4.4M | $5.7M | $6.8M | $242,900 | $290,815 | $439,806 |
| Inventory | — | $21,000 | $122,000 | $81,706 | $22,603 | $16,356 | $16,302 | $38,085 |
| Total assets | $20.4M | $5.5M | $7.2M | $6.5M | $7.6M | $687,649 | $664,670 | $859,211 |
| Total liabilities | $4.7M | $892,000 | $786,000 | $754,872 | $1.2M | $1.2M | $1.1M | $647,696 |
| Shareholders' equity | $16.0M | $4.7M | $6.5M | $5.8M | $6.5M | -$465,453 | -$402,119 | $218,227 |
Growth · year-over-year · Revenue CAGR -11.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue growth | — | -20.3% | -33.1% | -10.1% | +88.6% | +32.1% | -58.8% | — |
| EPS growth | — | — | -150.0% | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.